What is the share price of MPS Ltd (MPSLTD) today?
The share price of MPSLTD as on 19th June 2026 is ₹1812.10. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on MPS Ltd (MPSLTD) share?
The past returns of MPS Ltd (MPSLTD) share are- Past 1 week: 1.73%
- Past 1 month: 0.11%
- Past 3 months: 20.00%
- Past 6 months: -9.25%
- Past 1 year: -28.92%
- Past 3 years: 50.75%
- Past 5 years: 233.01%
What are the peers or stocks similar to MPS Ltd (MPSLTD)?
The peers or stocks similar to MPS Ltd (MPSLTD) include:What is the market cap of MPS Ltd (MPSLTD) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of MPS Ltd (MPSLTD) is ₹3074.40 Cr as of 19th June 2026.What is the 52 week high and low of MPS Ltd (MPSLTD) share?
The 52-week high of MPS Ltd (MPSLTD) is ₹2975 and the 52-week low is ₹1336.10.What is the PE and PB ratio of MPS Ltd (MPSLTD) stock?
The P/E (price-to-earnings) ratio of MPS Ltd (MPSLTD) is 17.75. The P/B (price-to-book) ratio is 6.43.Which sector does MPS Ltd (MPSLTD) belong to?
MPS Ltd (MPSLTD) belongs to the Communication Services sector & Publishing sub-sector.How to buy MPS Ltd (MPSLTD) shares?
You can directly buy MPS Ltd (MPSLTD) shares on Tickertape. Simply sign up, connect your demat account and place your order.
MPS Ltd
MPSLTD Share Price
NSEMPSLTD Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MPSLTD Performance & Key Metrics
MPSLTD Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 17.75 | 6.43 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 32.22 | 8.78 | 1.17% |
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
MPSLTD Company Profile
MPS Limited provides publishing solutions, including typesetting and data digitization services for overseas publishers and supports international publishers through every stage of the publishing process.
MPSLTD Sentiment Analysis
MPSLTD Sentiment Analysis
MPSLTD Stock Summary · February 2026
MPS Limited's Q3 FY'26 results reflect a complex landscape, marked by a slight revenue decline yet a robust EBITDA margin, particularly driven by the Education Solutions segment's strong growth. While the Corporate Learning division faces challenges, management is optimistic about future performance, anticipating a return to growth in FY'27, supported by strategic acquisitions like Unbound Medicine, which is expected to enhance B2B offerings in healthcare education. The company is prioritizing operational efficiency and deepening existing client relationships, particularly in the U.K. and Europe, while also exploring AI-driven innovations to capture market share. Despite recent performance concerns, the outlook remains cautiously optimistic, with expectations of exceeding an EPS of INR 100, bolstered by long-term contracts and a focus on high-value services.
MPSLTD Stock Growth Drivers
MPSLTD Stock Growth Drivers
8Strong Performance in Research Solutions
The Research Solutions segment has demonstrated significant achievements, contributing approximately 61.1% of total revenue in
Growth in Education Solutions
The Education Solutions segment reported an 11.3% year-on-year revenue growth in Q3 FY’26, with EBITDA
MPSLTD Stock Challenges
MPSLTD Stock Challenges
5Mixed Financial Performance
MPS Limited's financial results for Q3 and the first nine months of FY'26 reflect a
Challenges in Corporate Learning Segment
The Corporate Learning segment has faced significant challenges, prompting a strategic shift away from low-margin
MPSLTD Forecast
MPSLTD Forecasts
Price
Revenue
Earnings
MPSLTD Share Price Forecast
MPSLTD Share Price Forecast
All values in ₹
All values in ₹
MPSLTD Company Revenue Forecast
MPSLTD Company Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
MPSLTD Stock EPS (Earnings Per Share) Forecast
MPSLTD Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
MPSLTD
MPSLTD
Income
Balance Sheet
Cash Flow
MPSLTD Income Statement
MPSLTD Income Statement
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 135.22 | 151.93 | 182.77 | 179.28 | 188.14 | 195.12 | 193.41 | 209.53 | 184.58 | 212.08 | ||||||||||
| Operating & Other expenses | 89.17 | 106.66 | 139.67 | 124.20 | 126.02 | 126.10 | 136.62 | 133.97 | 132.29 | 137.65 | ||||||||||
| EBITDA | 46.05 | 45.27 | 43.10 | 55.08 | 62.12 | 69.02 | 56.79 | 75.56 | 52.29 | 74.43 | ||||||||||
| Depreciation/Amortization | 5.22 | 5.66 | 6.84 | 6.82 | 6.87 | 6.88 | 7.01 | 6.10 | 6.30 | 8.36 | ||||||||||
| PBIT | 40.83 | 39.61 | 36.26 | 48.26 | 55.25 | 62.14 | 49.78 | 69.46 | 45.99 | 66.07 | ||||||||||
| Interest & Other Items | 0.18 | 0.35 | 0.18 | 0.20 | 0.16 | 0.24 | 0.28 | 0.29 | 0.28 | 1.16 | ||||||||||
| PBT | 40.65 | 39.26 | 36.08 | 48.06 | 55.09 | 61.90 | 49.50 | 69.17 | 45.71 | 64.91 | ||||||||||
| Taxes & Other Items | 10.92 | 10.55 | 10.19 | 12.82 | 14.38 | 14.83 | 14.26 | 13.73 | 10.21 | 17.87 | ||||||||||
| Net Income | 29.73 | 28.71 | 25.89 | 35.24 | 40.71 | 47.07 | 35.24 | 55.44 | 35.50 | 47.04 | ||||||||||
| EPS | 17.53 | 17.12 | 15.27 | 20.77 | 24.00 | 27.76 | 20.78 | 32.67 | 20.93 | 27.72 |
MPSLTD Company Updates
Investor Presentation
MPSLTD Stock Peers
MPSLTD Past Performance & Peer Comparison
MPSLTD Past Performance & Peer Comparison
Communication ServicesPublishing
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| MPS Ltd | 17.75 | 6.43 | — |
| DB Corp Ltd | 10.96 | 1.64 | 3.43% |
| Navneet Education Ltd | 8.75 | 1.64 | 1.08% |
| Jagran Prakashan Ltd | 7.30 | 0.69 | 15.14% |
MPSLTD Stock Price Comparison
Compare MPSLTD with any stock or ETFMPSLTD Holdings
MPSLTD Shareholdings
MPSLTD Promoter Holdings Trend
MPSLTD Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
MPSLTD Institutional Holdings Trend
MPSLTD Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
MPSLTD Shareholding Pattern
MPSLTD Shareholding Pattern
MPSLTD Shareholding History
MPSLTD Shareholding History
Mutual Funds Invested in MPSLTD
Mutual Funds Invested in MPSLTD
No mutual funds holding trends are available
Top 2 Mutual Funds holding MPS Ltd
| Funds (Top 2) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1018% | Percentage of the fund’s portfolio invested in the stock 1.39% | Change in the portfolio weight of the stock over the last 3 months 0.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 43/62 (-10) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0001% | Percentage of the fund’s portfolio invested in the stock 0.00% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 461/1010 (-266) |
Compare 3-month MF holding change on Screener
smallcases containing MPSLTD stock
smallcases containing MPSLTD stock
Looks like this stock is not in any smallcase yet.
MPSLTD Events
MPSLTD Events
MPSLTD Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
MPSLTD Dividend Trend
No dividend trend available
MPSLTD Upcoming Dividends
MPSLTD Upcoming Dividends
No upcoming dividends are available
MPSLTD Past Dividends
MPSLTD Past Dividends
Cash Dividend
Ex DateEx DateAug 13, 2025
Dividend/Share
₹50.00
Ex DateEx Date
Aug 13, 2025
Cash Dividend
Ex DateEx DateJan 29, 2025
Dividend/Share
₹33.00
Ex DateEx Date
Jan 29, 2025
Cash Dividend
Ex DateEx DateAug 1, 2024
Dividend/Share
₹45.00
Ex DateEx Date
Aug 1, 2024
Cash Dividend
Ex DateEx DateNov 6, 2023
Dividend/Share
₹30.00
Ex DateEx Date
Nov 6, 2023
Cash Dividend
Ex DateEx DateJul 24, 2023
Dividend/Share
₹20.00
Ex DateEx Date
Jul 24, 2023
MPSLTD Stock News & Opinions
MPSLTD Stock News & Opinions
The Board of MPS at the meeting held on 15th May 2026, has decided not to recommend a final dividend for the financial year 2025-26.
Net profit of MPS declined 0.06% to Rs 47.04 crore in the quarter ended March 2026 as against Rs 47.07 crore during the previous quarter ended March 2025. Sales rose 12.66% to Rs 205.16 crore in the quarter ended March 2026 as against Rs 182.11 crore during the previous quarter ended March 2025. For the full year,net profit rose 16.33% to Rs 173.22 crore in the year ended March 2026 as against Rs 148.91 crore during the previous year ended March 2025. Sales rose 5.71% to Rs 768.37 crore in the year ended March 2026 as against Rs 726.89 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales205.16182.11 13 768.37726.89 6 OPM %32.9130.76 -30.6929.01 - PBDT72.9162.87 16 249.42222.63 12 PBT64.5555.99 15 221.65195.22 14 NP47.0447.07 0 173.22148.91 16 Powered by Capital Market - Live
MPS will hold a meeting of the Board of Directors of the Company on 15 May 2026.
MPS announced that its wholly owned subsidiary, MPS North America LLC has concluded the acquisition of 100% stake in Unbound Medicine Inc., USA for a total consideration of USD 16.5 million. Accordingly, Unbound Medicine, Inc., USA has become a wholly-owned step-down subsidiary of MPS. Powered by Capital Market - Live
Net profit of MPS declined 12.80% to Rs 35.50 crore in the quarter ended December 2025 as against Rs 40.71 crore during the previous quarter ended December 2024. Sales declined 2.08% to Rs 182.49 crore in the quarter ended December 2025 as against Rs 186.36 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales182.49186.36 -2 OPM %31.5532.38 - PBDT59.3961.96 -4 PBT53.0955.09 -4 NP35.5040.71 -13 Powered by Capital Market - Live
The acquisition will be executed through MPS North America LLC, a wholly owned subsidiary of MPS. The transaction is expected to be completed on or before 10 February 2026, subject to the fulfilment of customary closing conditions, the company said in a regulatory filing. The acquisition will be carried out for a cash consideration of $16.50 million, subject to customary adjustments. Founded in 1999, Unbound Medicine provides digital medical reference tools, clinical decision-support solutions and healthcare learning platforms. Its services are delivered through proprietary mobile and web-based platforms and follow a subscription-led institutional business model. The company serves medical schools, hospital systems and healthcare associations across the United States and Canada. MPS said the acquisition aligns with its strategy of building platform-led, recurring-revenue businesses. The transaction is expected to support revenue diversification, enable cross-selling opportunities and strengthen the company's presence in the North American market. MPS provides learning and platform solutions combining content, technology and artificial intelligence. The company is focused on scaling operations and strengthening its position in the global learning and knowledge services market. On a consolidated basis, net profit of MPS rose 57.32% to Rs 55.44 crore while net sales rose 9.42% to Rs 194.44 crore in Q2 September 2025 over Q2 September 2024. Powered by Capital Market - Live
The acquisition will be executed through MPS North America LLC, a wholly owned subsidiary of MPS. The transaction is expected to be completed on or before 10 February 2026, subject to the fulfilment of customary closing conditions, the company said in a regulatory filing. The acquisition will be carried out for a cash consideration of $16.50 million, subject to customary adjustments. Founded in 1999, Unbound Medicine provides digital medical reference tools, clinical decision-support solutions and healthcare learning platforms. Its services are delivered through proprietary mobile and web-based platforms and follow a subscription-led institutional business model. The company serves medical schools, hospital systems and healthcare associations across the United States and Canada. MPS said the acquisition aligns with its strategy of building platform-led, recurring-revenue businesses. The transaction is expected to support revenue diversification, enable cross-selling opportunities and strengthen the company's presence in the North American market. MPS provides learning and platform solutions combining content, technology and artificial intelligence. The company is focused on scaling operations and strengthening its position in the global learning and knowledge services market. On a consolidated basis, net profit of MPS rose 57.32% to Rs 55.44 crore while net sales rose 9.42% to Rs 194.44 crore in Q2 September 2025 over Q2 September 2024. Shares of MPS rose 3.46% to settle at Rs 1884.80 on Friday, 30 January 2026. Powered by Capital Market - Live
MPS will hold a meeting of the Board of Directors of the Company on 2 February 2026.Powered by Capital Market - Live
Net profit of MPS rose 57.32% to Rs 55.44 crore in the quarter ended September 2025 as against Rs 35.24 crore during the previous quarter ended September 2024. Sales rose 9.42% to Rs 194.44 crore in the quarter ended September 2025 as against Rs 177.70 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales194.44177.70 9 OPM %31.1030.11 - PBDT62.4654.88 14 PBT56.3648.06 17 NP55.4435.24 57 Powered by Capital Market - Live
MPS will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 16.21%, vs industry avg of 2.19%
Over the last 5 years, market share increased from 3.53% to 6.71%
Over the last 5 years, net income has grown at a yearly rate of 20%, vs industry avg of 23.52%